Humoral and Cellular Response in Shift Workers
Vaccination Against Hepatitis A Virus in Shift Workers: Evaluation of the Humoral and Cellular Immune Response
1 other identifier
interventional
34
1 country
2
Brief Summary
The purpose of this study is to access whether shift workers (morning, afternoon or night) vaccinated against hepatitis A would have some humoral and cellular response impairment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2013
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 2, 2012
CompletedFirst Posted
Study publicly available on registry
February 8, 2012
CompletedStudy Start
First participant enrolled
January 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2016
CompletedJanuary 11, 2018
January 1, 2018
1.7 years
February 2, 2012
January 9, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Antibodies against hepatitis A virus (anti-HAV)
Change in antibodies against hepatitis A virus (anti-HAV) production
Baseline, 30 days, 60 days and 90 days
Secondary Outcomes (6)
Intracellular cytokines
Baseline, 30 days, 60 days and 90 days
Catecholamines
Baseline, 30 days, 60 days and 90 days
Prolactin
Baseline, 30 days, 60 days and 90 days
Growth hormone
Baseline, 30 days, 60 days and 90 days
Cortisol
Baseline, 30 days, 60 days and 90 days
- +1 more secondary outcomes
Study Arms (1)
Shiftwork
EXPERIMENTALThe comparison will consider nightworkers versus dayworkers.
Interventions
Vaccination against hepatitis A (2 doses) into the deltoid muscle of the nondominant arm twice, i.e., at 0 and 6 months.
Eligibility Criteria
You may qualify if:
- shift workers
- naive immune status against hepatitis A confirmed by hepatitis A virus (HAV) antibodies levels below 5 mIU/mL
You may not qualify if:
- smokers
- individuals with complaints and/or sleep disorders
- acute or chronic disease
- use of medication during the study period.
- acute illnesses
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Centro de Estudos em Psicobiologia e Exercicio _ CEPE
São Paulo, São Paulo, 04020050, Brazil
Centro de Estudos em Psicobiologia e Exercicio - CEPE
São Paulo, 04020050, Brazil
Related Links
Study Officials
- STUDY DIRECTOR
Marco Tulio Mello, Associate Professor
Federal University of São Paulo
- STUDY CHAIR
Francieli Silva Ruiz, PhD
Federal University of São Paulo
- STUDY CHAIR
Andrea Maculano, PhD
Federal University of São Paulo
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
February 2, 2012
First Posted
February 8, 2012
Study Start
January 1, 2013
Primary Completion
September 1, 2014
Study Completion
December 1, 2016
Last Updated
January 11, 2018
Record last verified: 2018-01